Evidence map›Paper›PMID 40682761›Full record

ReviewDiscover oncology2025

Evaluation of human papillomavirus as a risk factor in prostate cancer pathogenesis.

Richard Maliye, Shari Babu, Anna E Harris, Rodhan Patke, Atara I Ntekim, Catrin S Rutland, Victoria James, Nigel P Mongan, Srinivasan Madhusudan, Jennie N Jeyapalan and 1 more

Abstract readReview
In one paragraph

Review in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Richard MaliyeSchool of Medicine, University of Zambia, Lusaka, Zambia.
Shari BabuSchool of Medicine, University of Zambia, Lusaka, Zambia.
Anna E HarrisFaculty of Medicine and Health Science, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK.
Rodhan PatkeFaculty of Medicine and Health Science, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK.
Atara I NtekimDepartment of Radiation Oncology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Catrin S RutlandFaculty of Medicine and Health Science, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK.
Victoria JamesFaculty of Medicine and Health Science, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK.
Nigel P MonganFaculty of Medicine and Health Science, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK.
Srinivasan MadhusudanFaculty of Medicine and Health Science, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK.
Jennie N JeyapalanFaculty of Medicine and Health Science, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK. jennie.jeyapalan@nottingham.ac.uk.
Musalwa Muyangwa SemenovaSchool of Medicine, University of Zambia, Lusaka, Zambia. musalwa.semenova@unza.zm.

Funding

Biotechnology and Biological Sciences Research Council BB/M008770/1Biotechnology and Biological Sciences Research Council BB/T008369/1
6 · The paper itself

Abstract

Prostate cancer (PCa) is the most prevalent and leading cause of cancer-related deaths among men in most countries around the world, with sub-Saharan Africa being among the most severely affected regions. Indeed, PCa is more common and lethal in indigenous African men, African Americans, and Afro-Caribbean men as compared to their age-matched white counterparts. While the fundamental aetiology of PCa and the role of androgen signalling are well understood, the basis of this racial disparity in PCa incidence and progression remains poorly understood. In this review we revisit the potential association of human papilloma virus (HPV) and PCa. While several studies support an association between HPV and PCa progression and aggressiveness, the importance of HPV in PCa is not without controversy. Here we evaluate studies that both support and challenge a mechanistic role for HPV in PCa and discuss limitations of these studies. We offer suggestions for future studies to address the contribution of HPV to the racial disparity in PCa incidence and outcomes.

Indexed as

Benign prostate hyperplasiaHuman papillomavirusOncogenesisProstate cancer

Identifiers

PMID40682761
PMCPMC12276187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.